# Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

> **NCT02974439** · PHASE1 · COMPLETED · sponsor: **Shanghai Haini Pharmaceutical Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** LANDI-Amlodipine Besylate Tablet 5mg
- **DRUG:** Norvasc Tablets 5mg

## Key facts

- **NCT ID:** NCT02974439
- **Lead sponsor:** Shanghai Haini Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-23
- **Primary completion:** 2017-03-21
- **Final completion:** 2017-03-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02974439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02974439, "Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT02974439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*